According to these analyses, 17.4% of the cases were quadruple-positive for IGF-1R, EP2/EP4, MAP4K3, and PKC-θ, indicating that crosstalk may occur between these signaling pathways in human pancreatic cancers. The gene discussed is PRRT2; the disease is pancreatic neoplasm.